Detalhe da pesquisa
1.
The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels.
BMC Cancer
; 19(1): 487, 2019 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31122212
2.
Real-World Effectiveness and Tolerability of Pazopanib as First Targeted Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Chart Review in Latin America.
Adv Ther
; 36(12): 3446-3457, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31630333